Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 CPT code 88361

Morphometric analysis, tumor immunohistochemistry (e.g., Her-2/neu, estrogen receptor, progesterone receptor), quantitative or semiquantitative, per specimen, each single antibody stain procedure; using computer-assisted technology.

Report 88361 once per specimen for each single antibody stain procedure analyzed using computer-assisted technology.

Modifiers 26 (Professional component) and TC (Technical component) may be used to report the professional or technical aspects of the procedure separately.

Medical necessity for this code must be supported by the clinical indication for the test (e.g., suspected breast cancer, melanoma). The test must be necessary for diagnostic or treatment planning purposes.

The pathologist is responsible for interpreting the stained slides and computer-generated results to provide a pathologic diagnosis.

IMPORTANT:Do not report 88360, 88361 in conjunction with 88341, 88342, or 88344 unless each procedure is for a different antibody. Morphometric analysis of a multiplex antibody stain should be reported with one unit of 88360 or 88361, per specimen. For morphometric analysis using in situ hybridization techniques, see 88367, 88368. When semi-thin plastic-embedded sections are performed in conjunction with morphometric analysis, only the morphometric analysis should be reported; if performed as an independent procedure, see codes 88300-88309 for surgical pathology.

In simple words: This test helps doctors understand certain characteristics of tumors by analyzing how they react to special stains. A computer helps count the stained cells, and a doctor then uses this information to make a diagnosis and guide treatment decisions.

This code represents a quantitative or semiquantitative immunohistochemistry (IHC) analysis of a tumor specimen using computer-assisted technology.A single antibody stain is applied to the specimen, and the computer assists in quantifying or semi-quantifying the stained cells. The pathologist then interprets the results to provide a diagnosis. This procedure is often used for biomarkers such as Her-2/neu, estrogen receptor, and progesterone receptor.

Example 1: A patient with suspected breast cancer has a biopsy performed. The specimen is sent for IHC staining for estrogen receptor and progesterone receptor, using computer-assisted technology to quantify the stained cells. 88361 is reported., A patient with a melanoma undergoes surgery. The tumor specimen is tested for Her-2/neu expression using a computer-assisted IHC analysis to guide treatment. 88361 is reported., A patient has a biopsy of a suspicious skin lesion. The specimen is stained with a single antibody and analyzed with computer assistance to determine the percentage of stained cells for diagnostic purposes. 88361 is reported.

Documentation should include the type of specimen, the antibody used, the results of the analysis (quantitative or semiquantitative), and the pathologist's interpretation and diagnosis.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.